股本结构
单位：万股
| 公告日期 | 2024-05-08 | 2024-05-08 | 2024-02-22 | 2024-02-22 | 2023-11-02 | 2023-11-02 |
|---|---|---|---|---|---|---|
| 证券总股本 | 5377.18 | 5372.05 | 5372.05 | 5368.21 | 5366.53 | 5363.86 |
| 普通股本 | 5377.18 | 5372.05 | 5372.05 | 5368.21 | 5366.53 | 5363.86 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-05-01 | 2024-03-31 | 2024-02-15 | 2023-12-31 | 2023-10-26 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-05-08 | 5377.18 | 未披露 | 定期报告 | 2024-05-01 |
| 2024-05-08 | 5372.05 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of ordinary shares upon exercise of stock options
|
2024-03-31 |
| 2024-02-22 | 5372.05 | 未披露 | 定期报告 | 2024-02-15 |
| 2024-02-22 | 5368.21 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of ordinary shares upon vesting of restricted stock units
Issuance of ordinary shares in public offering, net of issuance costs of $1.4 million
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $153 thousand
|
2023-12-31 |
| 2023-11-02 | 5366.53 | 未披露 | 定期报告 | 2023-10-26 |
| 2023-11-02 | 5363.86 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of ordinary shares upon exercise of stock options
|
2023-09-30 |
| 2023-08-03 | 5353.53 | 未披露 | 定期报告 | 2023-07-28 |
| 2023-08-03 | 5349.35 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $119 thousand
Issuance of ordinary shares upon exercise of stock options
|
2023-06-30 |
| 2023-05-04 | 5275.18 | 未披露 | 定期报告 | 2023-04-28 |
| 2023-05-04 | 5267.82 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of ordinary shares from the underwriters partial exercise of their 30-day option to purchase additional shares as part of the December 2022 public offering, net of issuance costs of $1.4 million
Issuance of ordinary shares upon exercise of stock options
|
2023-03-31 |
| 2023-03-31 | 5260.01 | 未披露 | 定期报告 | 2023-03-06 |
| 2023-02-28 | 5256.44 | 未披露 | 定期报告 | 2023-02-17 |
| 2023-02-28 | 5210.36 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of ordinary shares in public offering, net of issuance costs of $11.3 million
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $1.7 million
Issuance of ordinary shares upon exercise of stock options
|
2022-12-31 |
| 2022-12-16 | 5162.66 | 未披露 |
更多>>
Ordinary shares offered 3,250,000 shares by the company
|
2022-12-19 |
| 2022-11-03 | 4837.66 | 未披露 | 定期报告 | 2022-10-26 |
| 2022-11-03 | 4788.58 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $899 thousand
Issuance of ordinary shares upon exercise of stock options
|
2022-09-30 |
| 2022-08-08 | 4692.28 | 未披露 | 定期报告 | 2022-07-29 |
| 2022-08-08 | 4680.98 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $31 thousand
|
2022-06-30 |
| 2022-05-05 | 4680.62 | 未披露 | 定期报告 | 2022-04-28 |
| 2022-05-05 | 4674.98 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of ordinary shares upon exercise of stock options
|
2022-03-31 |
| 2022-03-31 | 4674.13 | 未披露 | 定期报告 | 2022-03-07 |
| 2022-02-25 | 4668.57 | 未披露 | 定期报告 | 2022-02-18 |
| 2022-02-17 | 4670.00 | 未披露 | 定期报告 | 2022-02-11 |
| 2022-02-25 | 4666.03 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares in public offering, net of issuance costs of $5.5 million
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $3.2 million
|
2021-12-31 |
| 2021-11-04 | 4659.38 | 未披露 | 定期报告 | 2021-10-28 |
| 2021-11-04 | 4653.32 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares in at-the-market offering, net of issuance costs of $2.7 million.
|
2021-09-30 |
| 2021-08-05 | 4504.74 | 未披露 | 定期报告 | 2021-07-29 |
| 2021-08-05 | 4491.30 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares in at-the-market offering, net of issuance costs of $0.5 million
|
2021-06-30 |
| 2021-05-20 | 4417.58 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares in public offering, net of issuance costs of $5.5 million
|
2021-03-31 |
| 2021-03-26 | 4342.14 | 未披露 |
更多>>
1.Ordinary shares the company is offering 3,500,000 shares.
2.The number of ordinary shares to be outstanding after this offering is based on 39,921,413 ordinary shares outstanding as of December 31, 2020.
|
2021-03-26 |
| 2021-03-31 | 4000.61 | 未披露 | 定期报告 | 2021-03-08 |
| 2021-02-26 | 3998.72 | 未披露 | 定期报告 | 2021-02-18 |
| 2021-02-26 | 3992.14 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of ordinary shares upon exercise of stock options
|
2020-12-31 |
| 2020-11-04 | 3990.00 | 未披露 | 定期报告 | 2020-10-30 |
| 2020-11-04 | 3992.14 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of ordinary shares upon exercise of stock options
|
2020-09-30 |
| 2020-05-06 | 3991.14 | 未披露 |
更多>>
from December 31, 2019 to March 31, 2020
Issuance of ordinary shares upon exercise of stock options
|
2020-03-31 |
| 2020-03-03 | 3991.14 | 未披露 | 定期报告 | 2020-02-21 |
| 2020-03-03 | 3989.86 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of ordinary shares upon exercise of stock options
|
2019-12-31 |
| 2019-08-06 | 3989.66 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Issuance of ordinary shares upon exercise of stock options
|
2019-06-30 |
| 2019-05-07 | 3986.46 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of ordinary shares upon exercise of stock options
|
2019-03-31 |
| 2019-03-15 | 3986.37 | 未披露 |
更多>>
from December 31, 2017 to September 30, 2018
Issuance of ordinary shares under share subscription agreement with Celgene
Issuance of ordinary shares upon exercise of stock options
|
2018-09-30 |
| 2018-08-07 | 3983.68 | 未披露 | 定期报告 | 2018-07-20 |
| 2018-08-07 | 3983.18 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-09 | 3982.23 | 未披露 | 定期报告 | 2018-04-20 |
| 2018-05-09 | 3982.18 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-29 | 3856.44 | 未披露 | 定期报告 | 2018-03-12 |
| 2018-02-26 | 3854.05 | 未披露 | 定期报告 | 2018-02-09 |
| 2018-02-26 | 3848.28 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of ordinary shares in public offering, net of issuance costs of $4.9 million
Issuance of ordinary shares upon exercise of stock options
|
2017-12-31 |
| 2017-11-07 | 3844.68 | 未披露 | 定期报告 | 2017-10-20 |
| 2017-11-07 | 3844.33 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-09 | 3827.51 | 未披露 | 定期报告 | 2017-07-21 |
| 2017-08-09 | 3815.70 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-09 | 3802.02 | 未披露 | 定期报告 | 2017-04-27 |
| 2017-05-09 | 3795.76 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-31 | 3794.09 | 未披露 | 定期报告 | 2017-03-13 |
| 2017-02-27 | 3502.87 | 未披露 | 定期报告 | 2017-02-10 |
| 2017-02-27 | 3475.21 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Issuance of ordinary shares in public offering, net of issuance costs of $8.5 million
Issuance of ordinary shares upon exercise of stock options
|
2016-12-31 |
| 2016-11-02 | 3448.84 | 未披露 | 定期报告 | 2016-10-21 |
| 2016-11-02 | 3438.15 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-02 | 3439.59 | 未披露 | 定期报告 | 2016-07-22 |
| 2016-08-02 | 3438.15 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-04 | 3434.92 | 未披露 | 定期报告 | 2016-04-22 |
| 2016-05-04 | 3434.02 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-04-04 | 3433.90 | 未披露 | 定期报告 | 2016-03-14 |
| 2016-02-25 | 3433.87 | 未披露 | 定期报告 | 2016-02-12 |
| 2016-02-25 | 3174.41 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Issuance of ordinary shares in public offering, net of issuance costs of $8.9 million
Issuance of ordinary shares upon exercise of stock options
|
2015-12-31 |
| 2015-11-02 | 3152.28 | 未披露 | 定期报告 | 2015-10-23 |
| 2015-11-02 | 3152.16 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-08-05 | 3138.00 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-05-06 | 3128.59 | 未披露 | 定期报告 | 2015-04-24 |
| 2015-05-06 | 2746.64 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-04-02 | 2740.27 | 未披露 | 定期报告 | 2015-03-16 |
| 2015-03-13 | 2739.95 | 未披露 | 定期报告 | 2015-02-27 |
| 2015-03-13 | 2738.80 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Issuance of ordinary shares in public offering, net of issuance costs of $5.5 million
Issuance of ordinary shares upon exercise of stock options
|
2014-12-31 |
| 2014-11-04 | 2738.41 | 未披露 | 定期报告 | 2014-10-24 |
| 2014-11-04 | 2738.16 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-08-05 | 2737.59 | 未披露 | 定期报告 | 2014-07-25 |
| 2014-08-05 | 2666.34 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-05-05 | 2190.48 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-03-31 | 2190.30 | 未披露 | 定期报告 | 2014-03-17 |
| 2014-03-07 | 2190.29 | 未披露 | 定期报告 | 2014-03-03 |
| 2014-03-07 | 2185.63 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Issuance of ordinary shares in public offering, net of issuance costs of $7.4 million
|
2013-12-31 |
| 2013-11-12 | 2185.63 | 未披露 | 定期报告 | 2013-10-31 |
| 2013-05-15 | 1767.92 | 未披露 | 定期报告 | 2013-04-30 |
| 2013-05-15 | 1767.90 | 未披露 | 定期报告 | 2013-03-31 |
| 2013-03-29 | 1767.92 | 未披露 | 定期报告 | 2013-02-28 |
| 2013-03-29 | 1767.90 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Contribution of net assets to Prothena and issuance of ordinary shares
Issuance of ordinary shares to Elan
|
2012-12-31 |
From December 31, 2023 to March 31, 2024
Issuance of ordinary shares upon exercise of stock options
From December 31, 2022 to December 31, 2023
Issuance of ordinary shares upon vesting of restricted stock units
Issuance of ordinary shares in public offering, net of issuance costs of $1.4 million
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $153 thousand
From June 30, 2023 to September 30, 2023
Issuance of ordinary shares upon exercise of stock options
From March 31, 2023 to June 30, 2023
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $119 thousand
Issuance of ordinary shares upon exercise of stock options
From December 31, 2022 to March 31, 2023
Issuance of ordinary shares from the underwriters partial exercise of their 30-day option to purchase additional shares as part of the December 2022 public offering, net of issuance costs of $1.4 million
Issuance of ordinary shares upon exercise of stock options
From December 31, 2021 to December 31, 2022
Issuance of ordinary shares in public offering, net of issuance costs of $11.3 million
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $1.7 million
Issuance of ordinary shares upon exercise of stock options
Ordinary shares offered 3,250,000 shares by the company
From June 30, 2022 to September 30, 2022
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $899 thousand
Issuance of ordinary shares upon exercise of stock options
From March 31, 2022 to June 30, 2022
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $31 thousand
From December 31, 2021 to March 31, 2022
Issuance of ordinary shares upon exercise of stock options
From December 31, 2020 to December 31, 2021
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares in public offering, net of issuance costs of $5.5 million
Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $3.2 million
From June 30, 2021 to September 30, 2021
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares in at-the-market offering, net of issuance costs of $2.7 million.
From March 31, 2021 to June 30, 2021
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares in at-the-market offering, net of issuance costs of $0.5 million
From December 31, 2020 to March 31, 2021
Issuance of ordinary shares upon exercise of stock options
Issuance of ordinary shares in public offering, net of issuance costs of $5.5 million
1.Ordinary shares the company is offering 3,500,000 shares.
2.The number of ordinary shares to be outstanding after this offering is based on 39,921,413 ordinary shares outstanding as of December 31, 2020.
From December 31, 2019 to December 31, 2020
Issuance of ordinary shares upon exercise of stock options
From June 30, 2020 to September 30, 2020
Issuance of ordinary shares upon exercise of stock options
from December 31, 2019 to March 31, 2020
Issuance of ordinary shares upon exercise of stock options
from December 31, 2018 to December 31, 2019
Issuance of ordinary shares upon exercise of stock options
from March 31, 2019 to June 30,2019
Issuance of ordinary shares upon exercise of stock options
from December 31, 2018 to March 31, 2019
Issuance of ordinary shares upon exercise of stock options
from December 31, 2017 to September 30, 2018
Issuance of ordinary shares under share subscription agreement with Celgene
Issuance of ordinary shares upon exercise of stock options
from December 31, 2016 to December 31, 2017
Issuance of ordinary shares in public offering, net of issuance costs of $4.9 million
Issuance of ordinary shares upon exercise of stock options
from December 31, 2015 to December 31, 2016
Issuance of ordinary shares in public offering, net of issuance costs of $8.5 million
Issuance of ordinary shares upon exercise of stock options
from December 31, 2014 to December 31, 2015
Issuance of ordinary shares in public offering, net of issuance costs of $8.9 million
Issuance of ordinary shares upon exercise of stock options
from December 31, 2013 to December 31, 2014
Issuance of ordinary shares in public offering, net of issuance costs of $5.5 million
Issuance of ordinary shares upon exercise of stock options
from December 31, 2012 to December 31, 2013
Issuance of ordinary shares in public offering, net of issuance costs of $7.4 million
from December 31, 2011 to December 31, 2012
Contribution of net assets to Prothena and issuance of ordinary shares
Issuance of ordinary shares to Elan